BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4757967)

  • 1. [The influence of testosterone on the anaemia of terminal renal failure (author's transl)].
    Augustin HJ; Kapaun W; Kötter C
    Dtsch Med Wochenschr; 1973 Nov; 98(45):2119-22. PubMed ID: 4757967
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma erythropoietin levels in patients undergoing long-term hemodialysis.
    Raich PC; Korst DR
    Arch Pathol Lab Med; 1978 Feb; 102(2):73-5. PubMed ID: 579968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Testosterone treatment of renal anemia. Evaluation of success by means of morphometric bone marrow and erythrocyte volume determinations].
    Keyssner J; Hauswaldt C; Uhl N; Hunstein W
    Schweiz Med Wochenschr; 1974 Dec; 104(52):1938-41. PubMed ID: 4432057
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythropoietin activity in anephric, allotransplanted, unilaterally nephrectomized and intact man.
    Mirand EA; Murphy GP; Steeves RA; Groenewald JM; DeKlerk JN
    J Lab Clin Med; 1969 Jan; 73(1):121-8. PubMed ID: 4883100
    [No Abstract]   [Full Text] [Related]  

  • 5. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
    Sobota JT
    Contrib Nephrol; 1989; 76():166-78; discussion 212-8. PubMed ID: 2684519
    [No Abstract]   [Full Text] [Related]  

  • 6. The hematologic effect of androgen in uremic patients. Study of packed cell volume and erythropoietin responses.
    Fried W; Jonasson O; Lang G; Schwartz F
    Ann Intern Med; 1973 Dec; 79(6):823-7. PubMed ID: 4761909
    [No Abstract]   [Full Text] [Related]  

  • 7. Human recombinant erythropoietin in the treatment of anaemia in chronic haemodialysis patients.
    Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartûsková J; Válek A
    Czech Med; 1990; 13(2-3):98-106. PubMed ID: 2245762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic renal failure and hematological disorders, particularly anemia (author's transl)].
    Setsuda T
    Rinsho Ketsueki; 1974 Feb; 15(2):143-7. PubMed ID: 4858657
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythropoietic effects of triiodothyronine on the anemia of renal failure in rats: comparative studies with testosterone and erythropoietin.
    Malgor LA; Barrios L; de Albarenque ME; Verges E; de Markowsky EE; Montiel E; Mussin SM
    Exp Hematol; 1986 May; 14(4):250-6. PubMed ID: 3699108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of androgens and dialysis on erythropoiesis in chronic renal failure.
    Yen MC; Ball JH; Lowrie EG; Lazarus JM; Hampers CL; Merrill JP
    Proc Clin Dial Transplant Forum; 1973; 3():33-8. PubMed ID: 4806648
    [No Abstract]   [Full Text] [Related]  

  • 11. [The recovery of erythropoiesis after the short-term Recormon treatment of renal anemia].
    Nikolaev AIu; Klepikov PV; Lashutin SV
    Ter Arkh; 1992; 64(6):90-1. PubMed ID: 1440349
    [No Abstract]   [Full Text] [Related]  

  • 12. Androgenic steroids in anemia of chronic renal failure.
    Wombolt DG; Oller NS
    Va Med Mon (1918); 1974 Oct; 101(10):846-8. PubMed ID: 4456865
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anemia in chronic renal insufficiency].
    Heilmann E
    Fortschr Med; 1975 Dec; 93(34):1718-20. PubMed ID: 1193526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of anemia associated with chronic renal failure. II. Effects of blood transfusion on erythropoiesis in long-term hemodialized patients (author's transl)].
    Moriyama Y; Ono Y; Sato M; Kurokawa I; Nishino I
    Rinsho Ketsueki; 1973 Oct; 14(10):1001-7. PubMed ID: 4796984
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of anaemia in chronic renal failure.
    Beer J
    Nurs Times; 1988 Nov 23-29; 84(47):55-7. PubMed ID: 3211795
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of recombinant human erythropoietin (rHu-EPO) on anemia and selected biochemical parameters in patients in the pre-dialysis period].
    Sułowicz W; Drozdz M; Hanicki Z; Kraśniak A; Kuźniewski M
    Przegl Lek; 1992; 49(1-2):50-3. PubMed ID: 1455007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anemia of chronic renal failure: pathophysiology and effects of recombinant erythropoietin.
    Eschbach JW; Haley NR; Adamson JW
    Contrib Nephrol; 1990; 78():24-36; discussion 37. PubMed ID: 2225841
    [No Abstract]   [Full Text] [Related]  

  • 18. Recombinant human erythropoietin for anaemia associated with chronic renal failure in predialysis patients.
    Schaefer RM; Schaefer L; Heidland A
    Przegl Lek; 1992; 49(1-2):41-2. PubMed ID: 1455005
    [No Abstract]   [Full Text] [Related]  

  • 19. [Further studies on the effectiveness of erythropoietin in renal failure (author's transl)].
    Essers U; Müller W; Brunner E
    Dtsch Med Wochenschr; 1974 Aug; 99(32):1618-20 passim. PubMed ID: 4843513
    [No Abstract]   [Full Text] [Related]  

  • 20. Human recombinant erythropoietin (rHuEPO) in the treatment of anemia in patients with chronic renal failure (CRF): experience with a group of patients on chronic haemodialysis treatment.
    Ramírez B; Flores A; Pérez F; Córdoba C; García L; Vázquez G
    Transplant Proc; 1991 Apr; 23(2):1833-4. PubMed ID: 2053170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.